ANTI-PD-1 ANTIBODY
Clinical trials for ANTI-PD-1 ANTIBODY explained in plain language.
Never miss a new study
Get alerted when new ANTI-PD-1 ANTIBODY trials appear
Sign up with your email to follow new studies for ANTI-PD-1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough combo aims to beat hepatitis b for good
Disease control Recruiting nowThis study tests a new combination of drugs to help people with chronic hepatitis B achieve a 'functional cure'—meaning the virus is no longer active in the body. About 120 adults aged 18-70 will receive an immune-boosting drug (anti-PD-1 antibody) along with standard antivirals.…
Matched conditions: ANTI-PD-1 ANTIBODY
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Breakthrough combo aims to cure hepatitis b in over 50% of patients
Disease control Recruiting nowThis study tests a new combination of drugs (an immune checkpoint inhibitor and interferon) to help the body clear the hepatitis B virus. The goal is to achieve a functional cure, meaning the virus is controlled without lifelong medication. About 120 adults with chronic hepatitis…
Matched conditions: ANTI-PD-1 ANTIBODY
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated May 11, 2026 20:53 UTC